Y
Yoshie Sakamaki Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
faculty
8 h-index
20 pubs
239 cited
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Yoshie Sakamaki's research focuses on the development and application of novel compounds for cancer therapy. Her work involves the synthesis of organometallic complexes and nanostructures for targeted drug delivery, particularly in photodynamic therapy. Recent publications highlight the investigation of bioconjugated chlorin-based metal–organic frameworks for treating triple-negative breast and pancreatic cancers. Additionally, her research explores luminescent heterobimetallic PtII–AuI complexes as potential anticancer agents. Sakamaki has a publication record of 20 papers with 232 citations and an h-index of 8. She collaborates with researchers at the University of Arkansas at Fayetteville, including M. Hassan Beyzavi, Jin-Woo Kim, Yuchun Du, and Zachary McConnell.
Metrics
- h-index: 8
- Publications: 20
- Citations: 239
Selected Publications
-
Luminescent Heterobimetallic Pt<sup>II</sup>–Au<sup>I</sup> Complexes Bearing <i>N</i>-Heterocyclic Carbenes (NHCs) as Potent Anticancer Agents (2023)
-
A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers (2021)
Collaboration Network
Top Collaborators
M. Hassan Beyzavi
5 shared publications
In database
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
- Luminescent Heterobimetallic Pt<sup>II</sup>–Au<sup>I</sup> Complexes Bearing <i>N</i>-Heterocyclic Carbenes (NHCs) as Potent Anticancer Agents
- CCDC 2255871: Experimental Crystal Structure Determination
- CCDC 2255870: Experimental Crystal Structure Determination
- CCDC 2255869: Experimental Crystal Structure Determination
Vahideh Dolatyari
4 shared publications
- Luminescent Heterobimetallic Pt<sup>II</sup>–Au<sup>I</sup> Complexes Bearing <i>N</i>-Heterocyclic Carbenes (NHCs) as Potent Anticancer Agents
- CCDC 2255871: Experimental Crystal Structure Determination
- CCDC 2255870: Experimental Crystal Structure Determination
- CCDC 2255869: Experimental Crystal Structure Determination
Hamid R. Shahsavari
4 shared publications
- Luminescent Heterobimetallic Pt<sup>II</sup>–Au<sup>I</sup> Complexes Bearing <i>N</i>-Heterocyclic Carbenes (NHCs) as Potent Anticancer Agents
- CCDC 2255871: Experimental Crystal Structure Determination
- CCDC 2255870: Experimental Crystal Structure Determination
- CCDC 2255869: Experimental Crystal Structure Determination
Masood Fereidoonnezhad
4 shared publications
- Luminescent Heterobimetallic Pt<sup>II</sup>–Au<sup>I</sup> Complexes Bearing <i>N</i>-Heterocyclic Carbenes (NHCs) as Potent Anticancer Agents
- CCDC 2255871: Experimental Crystal Structure Determination
- CCDC 2255870: Experimental Crystal Structure Determination
- CCDC 2255869: Experimental Crystal Structure Determination
Fahimeh Farhadi
4 shared publications
- Luminescent Heterobimetallic Pt<sup>II</sup>–Au<sup>I</sup> Complexes Bearing <i>N</i>-Heterocyclic Carbenes (NHCs) as Potent Anticancer Agents
- CCDC 2255871: Experimental Crystal Structure Determination
- CCDC 2255870: Experimental Crystal Structure Determination
- CCDC 2255869: Experimental Crystal Structure Determination
Shiva Akhlaghi
4 shared publications
- Luminescent Heterobimetallic Pt<sup>II</sup>–Au<sup>I</sup> Complexes Bearing <i>N</i>-Heterocyclic Carbenes (NHCs) as Potent Anticancer Agents
- CCDC 2255871: Experimental Crystal Structure Determination
- CCDC 2255870: Experimental Crystal Structure Determination
- CCDC 2255869: Experimental Crystal Structure Determination
Camille Latouche
4 shared publications
- Luminescent Heterobimetallic Pt<sup>II</sup>–Au<sup>I</sup> Complexes Bearing <i>N</i>-Heterocyclic Carbenes (NHCs) as Potent Anticancer Agents
- CCDC 2255871: Experimental Crystal Structure Determination
- CCDC 2255870: Experimental Crystal Structure Determination
- CCDC 2255869: Experimental Crystal Structure Determination
John Ozdemir
University of Arkansas at Fayetteville
1 shared publication
In database
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
Zachary Heidrick
University of Arkansas at Fayetteville
1 shared publication
In database
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
Anthony Azzun
University of Arkansas at Fayetteville (US)
1 shared publication
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
Olivia Watson
University of Arkansas at Fayetteville (US)
1 shared publication
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
Miu Tsuji
University of Arkansas at Fayetteville (US)
1 shared publication
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
Christopher Salmon
University of Arkansas at Fayetteville
1 shared publication
In database
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
Arvind Sinha
University of Arkansas at Fayetteville (US)
1 shared publication
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
Joseph Batta‐Mpouma
University of Arkansas at Fayetteville
1 shared publication
In database
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
Similar Researchers
Based on overlapping research topics
Zachary McConnell
University of Arkansas at Fayetteville
Nanoparticle-Based Drug Delivery
Cancer Treatment and Pharmacology
Pancreatic and Hepatic Oncology Research
Christopher Salmon
University of Arkansas at Fayetteville
Nanoparticle-Based Drug Delivery
Cancer Treatment and Pharmacology
Pancreatic and Hepatic Oncology Research
David Fugitt
University of Arkansas at Fayetteville
Nanoparticle-Based Drug Delivery
Cancer Treatment and Pharmacology
Pancreatic and Hepatic Oncology Research
Nickolas Gustavison
University of Arkansas at Fayetteville
Nanoparticle-Based Drug Delivery
Cancer Treatment and Pharmacology
Pancreatic and Hepatic Oncology Research
Marius B. Nagalo
University of Arkansas for Medical Sciences
Nanoparticle-Based Drug Delivery
Cancer Treatment and Pharmacology
Pancreatic and Hepatic Oncology Research
John Ozdemir
University of Arkansas at Fayetteville
Nanoparticle-Based Drug Delivery
Cancer Treatment and Pharmacology
Pancreatic and Hepatic Oncology Research